Literature DB >> 28716335

Management of Chronic Total Coronary Occlusion in Stable Ischemic Heart Disease by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy.

Mony Shuvy1, Feng Qiu2, Alyssandra Chee-A-Tow1, John J Graham3, Wael Abuzeid1, Christopher Buller3, Bradley H Strauss1, Harindra C Wijeysundera4.   

Abstract

Coronary chronic total occlusions (CTOs) are found in approximately 20% of angiograms. We sought to assess the variation in the management of patients with CTOs and to compare the clinical outcomes of CTO lesions with those of non-CTO lesions. We conducted a population-based cohort study and included all patients with stable angina who underwent cardiac catheterization from October 1, 2012, to June 30, 2013, in Ontario, Canada. The primary outcome was a composite of mortality and hospitalization for myocardial infarction. A total of 7,864 patients were included, of whom 2,279 (29%) had a CTO. There were substantial differences in revascularization rates for patients with CTOs across hospitals in Ontario (44.9% to 94.1%). Revascularization was associated with improved outcomes in the overall cohort. Although the advantage of coronary artery bypass grafting over medical therapy was consistent in both patients with CTOs and patients without CTOs, the benefit of percutaneous coronary intervention (PCI) was limited to patients without CTOs (hazard ratio 0.56, 95% confidence interval 0.40- to 0.78), with no difference in patients with CTOs. The CTO lesion, however, was revascularized in few of the PCI cases (41.1%), with PCI limited to the non-CTO lesion in most patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28716335     DOI: 10.1016/j.amjcard.2017.05.061

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis.

Authors:  Ka Hou Christien Li; Ka Hei Gabriel Wong; Mengqi Gong; Tong Liu; Guangping Li; Yunlong Xia; Jeffery Ho; Luis Nombela-Franco; Abhishek C Sawant; Simon Eccleshall; Gary Tse; Vassilios S Vassiliou
Journal:  Curr Atheroscler Rep       Date:  2019-08-09       Impact factor: 5.113

Review 2.  The Canadian Contribution to Science, Techniques, Technology, and Education in Chronic Total Occlusion Percutaneous Coronary Intervention.

Authors:  Luiz F Ybarra; Christopher E Buller; Stéphane Rinfret
Journal:  CJC Open       Date:  2020-09-04

Review 3.  Overview of Contemporary Chronic Total Occlusion Percutaneous Coronary Intervention Techniques: A Narrative Systematic Review.

Authors:  Talal Aljabbary; Andriy Katyukha; Gabby Elbaz-Greener; Kassandra Gressmann; Akshay Bagai; John J Graham; Ram Vijayaraghavan; Sanjog Kalra; Minh Vo; Harindra C Wijeysundera
Journal:  CJC Open       Date:  2021-06-06

Review 4.  Revascularization of chronic total occlusion coronary artery and cardiac regeneration.

Authors:  Ruoxi Liao; Zhihong Li; Qiancheng Wang; Hairuo Lin; Huijun Sun
Journal:  Front Cardiovasc Med       Date:  2022-08-25

5.  Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.

Authors:  Fei Chen; Fan Liu; Jingchao Lu; Xiuchun Yang; Bing Xiao; Yaqiong Jin; Jie Zhang
Journal:  Eur J Med Res       Date:  2018-05-18       Impact factor: 2.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.